You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 131 No. 12, December 1995 TABLE OF CONTENTS
  Archives
  •  Online Features
  Observations
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Treatment of Cafe au Lait Macules With Lasers

A Clinicopathologic Correlation

Melanie C. Grossman, MD; R. Rox Anderson, MD; William Farinelli; Thomas J. Flotte, MD; Joop M. Grevelink, MD

Arch Dermatol. 1995;131(12):1416-1420.


Abstract

Background
Cafe au lait macules (CALMs) respond variably to treatment with different lasers. This study was done to determine whether the type of laser and the individual histologic features of the CALMs could predict clinical response to treatment. Nine CALMs were treated with both the frequency-doubled Q-switched neodymium: YAG laser (wavelength, 532 nm; beam diameter, 2.0 mm) and the Q-switched ruby laser (wavelength, 694 nm; beam diameter, 5.0 mm). Both lasers were used at a fluence of 6.0 J/cm2. Biopsy specimens of the CALMs were obtained before and after treatment. Clinical follow-up was done at 1-, 3-, and 6-month intervals.

Observations
Both lasers yielded variable responses to treatment. Two histologic subtypes of CALMs were identified, but these different subtypes did not predict clinical outcome after laser treatment.

Conclusions
Cafe au lait macules respond variably to treatment with both the Q-switched ruby laser and the frequency-doubled Q-switched neodymium:YAG laser. Further research might address the effect of using multiple treatments. In view of these results, clinicians using lasers to treat CALMs should inform their patients of the potential for recurrence or darkening of CALMs.

(Arch Dermatol. 1995;131:1416-1420)



Author Affiliations

From the Dermatology Laser Center, Massachusetts General Hospital, Boston.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Laser Treatment of Pigmented Lesions-2000: How Far Have We Gone?
Stratigos et al.
Arch Dermatol 2000;136:915-921.
FULL TEXT  

Treatment of Benign and Atypical Nevi With the Normal-Mode Ruby Laser and the Q-Switched Ruby Laser: Clinical Improvement but Failure to Completely Eliminate Nevomelanocytes
Duke et al.
Arch Dermatol 1999;135:290-296.
ABSTRACT | FULL TEXT  

Laser Treatment of Cafe-au-Lait Macules
Journal Watch Dermatology 1996;1996:12-12.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.